N-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide

C98H114F3N19O13 — CID 158452801

IUPACN-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide
SMILESC.C.CC(C)CCNC(=O)c1ccc2c(c1)nc(Nc1n[nH]c3ccc(-c4ccccc4OC(F)(F)F)cc13)n2C1CCC(O)CC1.Cc1cc(-c2nc(C(=O)Nc3cn(C4CCOCC4)nc3C(N)=O)co2)ccn1.Cc1cccc(C(=O)Nc2nc3cc(OC(=O)C(C)(C)C)ccc3n2CCCO)c1.Cc1cccc(C(=O)Nc2nc3ccccc3n2CCN2CCOCC2)c1
InChIInChI=1S/C33H35F3N6O3.C23H27N3O4.C21H24N4O2.C19H20N6O4.2CH4/c1-19(2)15-16-37-31(44)21-8-14-28-27(18-21)38-32(42(28)22-9-11-23(43)12-10-22)39-30-25-17-20(7-13-26(25)40-41-30)24-5-3-4-6-29(24)45-33(34,35)36;1-15-7-5-8-16(13-15)20(28)25-22-24-18-14-17(30-21(29)23(2,3)4)9-10-19(18)26(22)11-6-12-27;1-16-5-4-6-17(15-16)20(26)23-21-22-18-7-2-3-8-19(18)25(21)10-9-24-11-13-27-14-12-24;1-11-8-12(2-5-21-11)19-23-15(10-29-19)18(27)22-14-9-25(24-16(14)17(20)26)13-3-6-28-7-4-13;;/h3-8,13-14,17-19,22-23,43H,9-12,15-16H2,1-2H3,(H,37,44)(H2,38,39,40,41);5,7-10,13-14,27H,6,11-12H2,1-4H3,(H,24,25,28);2-8,15H,9-14H2,1H3,(H,22,23,26);2,5,8-10,13H,3-4,6-7H2,1H3,(H2,20,26)(H,22,27);2*1H4
InChIKeyHEEYUAGWXMTVLF-UHFFFAOYSA-N
MW1823.10 g/mol
LogP17.55
Rot. Bonds25

About N-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide

N-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide (PubChem CID 158452801) has the molecular formula C98H114F3N19O13 and a molecular weight of 1823.10 g/mol. Its IUPAC name is N-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide.

Molecular Properties

Compound NameN-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide
PubChem CID158452801
Molecular FormulaC98H114F3N19O13
Molecular Weight1823.10 g/mol
Exact Mass1821.88
IUPAC NameN-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide
SMILESC.C.CC(C)CCNC(=O)c1ccc2c(c1)nc(Nc1n[nH]c3ccc(-c4ccccc4OC(F)(F)F)cc13)n2C1CCC(O)CC1.Cc1cc(-c2nc(C(=O)Nc3cn(C4CCOCC4)nc3C(N)=O)co2)ccn1.Cc1cccc(C(=O)Nc2nc3cc(OC(=O)C(C)(C)C)ccc3n2CCCO)c1.Cc1cccc(C(=O)Nc2nc3ccccc3n2CCN2CCOCC2)c1
InChIInChI=1S/C33H35F3N6O3.C23H27N3O4.C21H24N4O2.C19H20N6O4.2CH4/c1-19(2)15-16-37-31(44)21-8-14-28-27(18-21)38-32(42(28)22-9-11-23(43)12-10-22)39-30-25-17-20(7-13-26(25)40-41-30)24-5-3-4-6-29(24)45-33(34,35)36;1-15-7-5-8-16(13-15)20(28)25-22-24-18-14-17(30-21(29)23(2,3)4)9-10-19(18)26(22)11-6-12-27;1-16-5-4-6-17(15-16)20(26)23-21-22-18-7-2-3-8-19(18)25(21)10-9-24-11-13-27-14-12-24;1-11-8-12(2-5-21-11)19-23-15(10-29-19)18(27)22-14-9-25(24-16(14)17(20)26)13-3-6-28-7-4-13;;/h3-8,13-14,17-19,22-23,43H,9-12,15-16H2,1-2H3,(H,37,44)(H2,38,39,40,41);5,7-10,13-14,27H,6,11-12H2,1-4H3,(H,24,25,28);2-8,15H,9-14H2,1H3,(H,22,23,26);2,5,8-10,13H,3-4,6-7H2,1H3,(H2,20,26)(H,22,27);2*1H4
InChIKeyHEEYUAGWXMTVLF-UHFFFAOYSA-N
XLogP17.55
TPSA408.09 Ų
H-Bond Donors9
H-Bond Acceptors26
Rotatable Bonds25
Heavy Atoms133
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001823.10
LogP ≤ 517.55
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phenol_ester', 'substructure': 'N/A'}

Analyze N-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

tert-butyl N-[4-[4-[[3-carbamoyl-1-[4-[3-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]propoxy]propyl-methylcarbamoyl]cyclohexyl]pyrazol-4-yl]carbamoyl]-1,3-oxazol-2-yl]-2-pyridinyl]-N-(2,2,2-trifluoroethyl)carbamate;N-[3-carbamoyl-1-[4-[3-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]propoxy]propyl-methylcarbamoyl]cyclohexyl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;4-[3-carbamoyl-4-[[2-[2-[(2-methylpropan-2-yl)oxycarbonyl-(2,2,2-trifluoroethyl)amino]-4-pyridinyl]-1,3-oxazole-4-carbonyl]amino]pyrazol-1-yl]cyclohexane-1-carboxylic acid;3-[3-methyl-4-[3-[3-(methylamino)propoxy]propyl]-2-oxobenzimidazol-1-yl]piperidine-2,6-dione;phosphanylphosphane
CID 157064188
1-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-3-[(4-fluorophenyl)methyl]urea;2-fluoro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-(trifluoromethyl)benzamide;2-methoxy-4-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-phenyl-1,3-oxazole-4-carboxamide
CID 157158634
N-(2,2-dimethyl-6-morpholin-4-yl-3H-1-benzofuran-5-yl)-2-methyl-3H-imidazo[4,5-c]pyridine-7-carboxamide;N-(2,2-dimethyl-6-morpholin-4-yl-3H-1-benzofuran-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-1,3-oxazole-4-carboxamide;N-(2,2-dimethyl-6-morpholin-4-yl-3H-1-benzofuran-5-yl)pyridine-2-carboxamide;N-(2,2-dimethyl-6-morpholin-4-yl-3H-1-benzofuran-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide;N-[(2R)-2-(hydroxymethyl)-2-methyl-6-morpholin-4-yl-3H-1-benzofuran-5-yl]pyrrolo[1,2-b]pyridazine-7-carboxamide
CID 157848477
N-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide
CID 158521479
CID 159625038
CID 159625038
azetidin-1-yl-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-[(4,7-difluoro-2-methyl-1H-indol-5-yl)oxy]pyrimidin-5-yl]methanone;azetidin-1-yl-[4-[(4,7-difluoro-2-methyl-1H-indol-5-yl)oxy]-6-[[5-(furan-2-yl)-1H-pyrazol-3-yl]amino]pyrimidin-5-yl]methanone;azetidin-1-yl-[4-[(4,7-difluoro-2-methyl-1H-indol-5-yl)oxy]-6-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]pyrimidin-5-yl]methanone;azetidin-1-yl-[4-[(4,7-difluoro-2-methyl-1H-indol-5-yl)oxy]-6-[[5-[(E)-prop-1-enyl]-1H-pyrazol-3-yl]amino]pyrimidin-5-yl]methanone
CID 159689855
N-tert-butyl-1-(4-hydroxycyclohexyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;(3S,4S,5S)-5-[[6-(3,3-dimethylbutanoyl)-7-methoxyisoquinolin-1-yl]oxymethyl]-4-ethyl-3-fluoropyrrolidin-2-one;1-[[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy]-7-[(2-methylpropan-2-yl)oxy]isoquinoline-6-carboxamide
CID 159825096
4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-N-ethyl-6-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-N-methylpyrimidine-5-carboxamide;N-ethyl-4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-[[5-(furan-2-yl)-1H-pyrazol-3-yl]amino]-N-methylpyrimidine-5-carboxamide;N-ethyl-4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-N-methyl-6-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]pyrimidine-5-carboxamide;N-ethyl-4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-N-methyl-6-[[5-[(E)-prop-1-enyl]-1H-pyrazol-3-yl]amino]pyrimidine-5-carboxamide
CID 159994074
4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-[(4,7-difluoro-2-methyl-1H-indol-5-yl)oxy]-N-ethyl-N-methylpyrimidine-5-carboxamide;4-[(4,7-difluoro-2-methyl-1H-indol-5-yl)oxy]-N-ethyl-6-[[5-(furan-2-yl)-1H-pyrazol-3-yl]amino]-N-methylpyrimidine-5-carboxamide;4-[(4,7-difluoro-2-methyl-1H-indol-5-yl)oxy]-N-ethyl-N-methyl-6-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]pyrimidine-5-carboxamide;4-[(4,7-difluoro-2-methyl-1H-indol-5-yl)oxy]-N-ethyl-N-methyl-6-[[5-[(E)-prop-1-enyl]-1H-pyrazol-3-yl]amino]pyrimidine-5-carboxamide
CID 160149471
5-(6-isocyano-1H-benzimidazol-4-yl)-2-methylphenol;5-(5-isocyano-1,3-benzoxazol-7-yl)-2-methylphenol;5-(6-isocyano-1,3-benzoxazol-4-yl)-2-methylphenol;5-(6-isocyanoimidazo[1,2-a]pyridin-8-yl)-2-methylphenol;5-(5-isocyano-3-methyl-2H-indazol-7-yl)-2-methylphenol;5-[5-isocyano-2-(trifluoromethyl)-1,3-benzoxazol-7-yl]-2-methylphenol;5-[6-isocyano-2-(trifluoromethyl)-1,3-benzoxazol-4-yl]-2-methylphenol
CID 160796793
CID 160969474
CID 160969474
(4R)-N-[4-[chloro(difluoro)methoxy]phenyl]-4-ethyl-6-pyridazin-4-yl-3,4-dihydro-1H-[1,4]oxazino[4,3-a]benzimidazole-8-carboxamide;(4R)-N-[4-[chloro(difluoro)methoxy]phenyl]-4-methyl-6-(1,3-oxazol-2-yl)-3,4-dihydro-1H-[1,4]oxazino[4,3-a]benzimidazole-8-carboxamide;(2R)-N-[4-[chloro(difluoro)methoxy]phenyl]-2-methyl-9-(1H-pyrazol-5-yl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazole-7-carboxamide;(4R)-N-[4-[chloro(difluoro)methoxy]phenyl]-4-methyl-6-pyridin-3-yl-3,4-dihydro-2H-[1,3]oxazino[3,2-a]benzimidazole-8-carboxamide;(4R)-4-methyl-6-(1H-pyrazol-5-yl)-N-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1H-[1,4]oxazino[4,3-a]benzimidazole-8-carboxamide;(4R)-4-methyl-6-pyridin-3-yl-N-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1H-[1,4]oxazino[4,3-a]benzimidazole-8-carboxamide
CID 161530265

Frequently Asked Questions

What is the IUPAC name of N-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide?
The IUPAC name of N-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide (CID 158452801) is N-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide.
What is the SMILES notation for N-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide?
The canonical SMILES for N-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide is C.C.CC(C)CCNC(=O)c1ccc2c(c1)nc(Nc1n[nH]c3ccc(-c4ccccc4OC(F)(F)F)cc13)n2C1CCC(O)CC1.Cc1cc(-c2nc(C(=O)Nc3cn(C4CCOCC4)nc3C(N)=O)co2)ccn1.Cc1cccc(C(=O)Nc2nc3cc(OC(=O)C(C)(C)C)ccc3n2CCCO)c1.Cc1cccc(C(=O)Nc2nc3ccccc3n2CCN2CCOCC2)c1.
What is the InChIKey of N-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide?
The InChIKey is HEEYUAGWXMTVLF-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H35F3N6O3.C23H27N3O4.C21H24N4O2.C19H20N6O4.2CH4/c1-19(2)15-16-37-31(44)21-8-14-28-27(18-21)38-32(42(28)22-9-11-23(43)12-10-22)39-30-25-17-20(7-13-26(25)40-41-30)24-5-3-4-6-29(24)45-33(34,35)36;1-15-7-5-8-16(13-15)20(28)25-22-24-18-14-17(30-21(29)23(2,3)4)9-10-19(18)26(22)11-6-12-27;1-16-5-4-6-17(15-16)20(26)23-21-22-18-7-2-3-8-19(18)25(21)10-9-24-11-13-27-14-12-24;1-11-8-12(2-5-21-11)19-23-15(10-29-19)18(27)22-14-9-25(24-16(14)17(20)26)13-3-6-28-7-4-13;;/h3-8,13-14,17-19,22-23,43H,9-12,15-16H2,1-2H3,(H,37,44)(H2,38,39,40,41);5,7-10,13-14,27H,6,11-12H2,1-4H3,(H,24,25,28);2-8,15H,9-14H2,1H3,(H,22,23,26);2,5,8-10,13H,3-4,6-7H2,1H3,(H2,20,26)(H,22,27);2*1H4.
What are the key properties of N-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide?
N-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide has a molecular weight of 1823.10 g/mol, XLogP of 17.55, 25 rotatable bonds, 9 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-carbamoyl-1-(oxan-4-yl)pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide;1-(4-hydroxycyclohexyl)-N-(3-methylbutyl)-2-[[5-[2-(trifluoromethoxy)phenyl]-1H-indazol-3-yl]amino]benzimidazole-5-carboxamide;[1-(3-hydroxypropyl)-2-[(3-methylbenzoyl)amino]benzimidazol-5-yl] 2,2-dimethylpropanoate;methane;3-methyl-N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]benzamide is sourced from PubChem (CID 158452801), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).